About Cetek Corporation

About company

Cetek Corporation is a biopharmaceutical company that engages in the discovery and development of novel cancer therapeutics. Its products include CTK110, a small molecule that shows in vitro and initial in vivo anticancer activity; CTK-100144, which has potent activity in vitro biochemical and cell-based assays; and CTK-100147 small molecules with highly selective and low nano-molar potency against the chymotrypsin. Cetek Corporation also provides contract services and discovery collaborations for various targets and therapeutic areas. The company was founded in 1996 and is headquartered in Marlborough, Massachusetts.